Quantitative Measurements of Codeine and Fentanyl on a Surface-Enhanced Raman-Active Pad Test.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
16 Jul 2019
Historique:
received: 17 06 2019
revised: 06 07 2019
accepted: 14 07 2019
entrez: 19 7 2019
pubmed: 19 7 2019
medline: 19 12 2019
Statut: epublish

Résumé

The USA is in the midst of an opioid crisis that included over 60,000 overdose fatalities in 2017, mostly unintentional. This is due to excessive use of prescription opioids and the use of very strong synthetic opioids, such as fentanyl, mixed with illicit street drugs. The ability to rapidly determine if people or packages entering the country have or contain drugs could reduce their availability, and thereby decrease the use of illicit drugs. In an effort to address this problem, we have been investigating the ability of surface-enhanced Raman spectroscopy to detect trace amounts of opioids on clothing and packages. Here, we report the measurement of codeine and fentanyl at 100 ng/mL for 5 min on a pad impregnated with gold colloids, as well as a preliminary measurement of 500 pg of fentanyl on a glass surface using one of these pads. The calculated limit of detection for this measurement was 40 pg. This data strongly suggests that these pads, used with portable Raman analyzers, would be invaluable to airport security, drug raids, crime scenes, and forensic analysis.

Identifiants

pubmed: 31315188
pii: molecules24142578
doi: 10.3390/molecules24142578
pmc: PMC6680930
pii:
doi:

Substances chimiques

Gold Colloid 0
Illicit Drugs 0
Fentanyl UF599785JZ
Codeine UX6OWY2V7J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Foundation for the National Institutes of Health
ID : 2R44DA032178-02

Références

Analyst. 2000 Mar;125(3):541-4
pubmed: 10829348
Analyst. 2001 Nov;126(11):2066-71
pubmed: 11763093
Analyst. 2002 Feb;127(2):282-6
pubmed: 11913874
J Pharm Biomed Anal. 2008 Jan 22;46(2):303-9
pubmed: 18054194
Spectrochim Acta A Mol Biomol Spectrosc. 2009 Jan;71(5):1984-8
pubmed: 19010725
J Forensic Sci. 2011 Jan;56(1):200-7
pubmed: 21198595
Anal Chem. 2013 Jan 15;85(2):923-31
pubmed: 23198960
Pharmaceutics. 2011 Jul 13;3(3):425-39
pubmed: 24310588
J Pharm Biomed Anal. 2017 Nov 30;146:420-425
pubmed: 28934694
JAMA. 2018 May 1;319(17):1819-1821
pubmed: 29715347
Anal Chem. 2018 Nov 6;90(21):12678-12685
pubmed: 30247896
Clin Pharmacol Ther. 1965 Nov-Dec;6(6):731-9
pubmed: 5321222

Auteurs

Chetan Shende (C)

Real-Time Analyzers, Inc., Middletown, CT 06457, USA.

Amelia Farquharson (A)

Real-Time Analyzers, Inc., Middletown, CT 06457, USA.

Carl Brouillette (C)

Real-Time Analyzers, Inc., Middletown, CT 06457, USA.

Wayne Smith (W)

Real-Time Analyzers, Inc., Middletown, CT 06457, USA.

Stuart Farquharson (S)

Real-Time Analyzers, Inc., Middletown, CT 06457, USA. stu@rta.biz.

Articles similaires

Humans United States Aged Cross-Sectional Studies Medicare Part C
Humans Emergency Service, Hospital Child Child, Preschool Infant
Humans Mobile Applications Hepatitis C Male Female

How Certification Exams Reflect Current Practice.

Tara L Myers, Sean DeGarmo, Marianne Horahan
1.00
Humans Certification Clinical Competence Education, Nursing, Continuing Adult

Classifications MeSH